Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

March 21, 2024 | Advisory board, DOL engagement, HCP engagement, HCP platform, Healthtech, Impetus Digital, KOL Engagement, MSL engagement, Pharma tips, Virtual advisory board, clinical trial, patient engagement 

Unlock the potential of asynchronous virtual meetings with the first tip from our “Top 10 Tips for Optimizing Asynchronous Virtual Meetings”.

- PMLiVE

Unlock the potential of asynchronous virtual meetings with our first essential tip. Discover the art of asking your advisors and stakeholders the right questions via the Impetus InSite Platform® to drive meaningful and insightful discussions.

1. Ask Open-Ended, Indirect Questions
Learn how to elevate your virtual meetings by avoiding yes/no questions. Instead, engage participants with open-ended inquiries that encourage descriptive answers. We’ll share how using words like “describe,” “explain,” and “compare” can significantly enhance dialogue depth. Also, get insights on how posing indirect questions can help capture genuine perspectives by asking about colleagues’ or patients’ views rather than direct personal opinions.

This video is a quick guide to optimizing your asynchronous virtual meetings, offering a glimpse into effective communication strategies that foster comprehensive engagement.

For more insights into optimizing your virtual meetings and engaging effectively with your stakeholders, continue watching our series. Discover the full range of tips and how the Impetus InSite Platform® can transform your digital interactions by visiting our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

Connect with Impetus Digital for deeper engagement:
Explore our solutions: www.impetusdigital.com
Schedule a conversation: https://meetwithimpetus.com/

Stay updated via our social channels:
LinkedIn: https://linkedin.com/company/impetus-digital
Twitter: https://twitter.com/impetus_digital
Facebook: https://facebook.com/ImpetusDigital.fb
Check out our podcast for more insights: https://impetusdigital.com/podcast/

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...